Contraception Clinical Trials

56 recruitingLast updated: June 18, 2026

There are 56 actively recruiting contraception clinical trials across 21 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include Seattle, Washington, United States, Salt Lake City, Utah, United States, Aurora, Colorado, United States. Updated daily from ClinicalTrials.gov.


Contraception Trials at a Glance

56 actively recruiting trials for contraception are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 25 trials, with the heaviest enrollment activity in Seattle, Salt Lake City, and Aurora. Lead sponsors running contraception studies include University of California, San Diego, Chulalongkorn University, and University of Colorado, Denver.

Browse contraception trials by phase

Treatments under study

About Contraception Clinical Trials

Looking for clinical trials for Contraception? There are currently 45 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Contraception trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Contraception clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 56 trials

Recruiting
Not Applicable

Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years

Women's healthPregnancySexual Health+7 more
Emory University400 enrolled4 locationsNCT05910580
Recruiting
Not Applicable

Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare

ContraceptionMaternal BehaviorHealth Literacy+4 more
Jackson State University250 enrolled1 locationNCT06481631
Recruiting
Not Applicable

Flo Digital Contraceptive Study

Contraception Use
Flo Health Inc.3,800 enrolled1 locationNCT07630064
Recruiting
Phase 4

Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo

emergency contraception
Lori Gawron790 enrolled1 locationNCT06162611
Recruiting

Female Reproductive Health in Canadian Armed Forces

Women's healthPregnancyInfertility+3 more
Université de Sherbrooke1,121 enrolled1 locationNCT07524764
Recruiting
Phase 3

Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception

Contraception
The University of Hong Kong980 enrolled1 locationNCT06727734
Recruiting
Phase 2

Long Term Evaluation of Scapular-inserted Contraceptive Implants

Contraception
Yale University62 enrolled2 locationsNCT07201402
Recruiting
Not Applicable

Contraceptive Efficacy Study of Ovaprene

Contraception
Daré Bioscience, Inc.656 enrolled27 locationsNCT06127199
Recruiting

Validation of Effectiveness on NaturalCycles Users

Contraception
Natural Cycles2,000 enrolled1 locationNCT07566793
Recruiting

Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women

ContraceptionIron Deficiencies
United States Army Research Institute of Environmental Medicine33 enrolled1 locationNCT06909695
Recruiting
Phase 4

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

Contraception
University of Utah1,404 enrolled8 locationsNCT05444582
Recruiting
Not Applicable

Kuwa Free! - Live Free!

HIV InfectionsContraceptionDrug-drug Interaction
University of Alabama at Birmingham700 enrolled1 locationNCT05044962
Recruiting
Phase 1Phase 2

Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study

Contraception
Chulalongkorn University16 enrolled1 locationNCT06345560
Recruiting
Not Applicable

Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study

Contraception
Chulalongkorn University16 enrolled1 locationNCT06345586
Recruiting
Not Applicable

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

Contraception
Femasys Inc.573 enrolled8 locationsNCT05977751
Recruiting
Not Applicable

Effect of Different Sex Hormone Profiles for the Response to Physical Training

EumenorrheaHormonal ContraceptionIntrauterine Devices, Medicated
University of Aarhus60 enrolled1 locationNCT07115849
Recruiting
Phase 3

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

Female Contraception
Mylan Pharmaceuticals Inc1,500 enrolled57 locationsNCT06672016
Recruiting
Not Applicable

Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period

ContraceptionSubstance Use DisordersPregnancy Related
University of Pittsburgh400 enrolled1 locationNCT04939012
Recruiting
Phase 1Phase 2

Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males

Male Contraception
YourChoice Therapeutics, Inc.88 enrolled1 locationNCT06542237
Recruiting
Phase 2

Effects of NLS-133, a Potential Non-Hormonal "On-Demand" Male Contraceptive

Male ContraceptionSemen VolumeSperm Motility
Next Life Sciences10 enrolled1 locationNCT07393334